Functional cell-based screening and saturation transfer double-difference NMR have identified haplosamate A as a cannabinoid receptor agonist

ACS Chemical Biology

Volumn 4, Issue 2, 2009, Pages 139-144

  Pereira, Alban ^a   Pfeifer, Tom A ^a   Grigliatti, Thomas A ^a   Andersen, Raymond J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR AGONIST; HAPLOSAMATE A; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOASSAY; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SOLUBILITY; FRACTIONATION; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL ASSAY; CELL LINE, TRANSFORMED; HUMANS; INSECTS; MAGNETIC RESONANCE SPECTROSCOPY; PAPUA NEW GUINEA; PORIFERA; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; STEROLS; TISSUE EXTRACTS;

HEXAPODA; PHOS;

EID: 65249108712     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb800264k     Document Type: Article

References (19)

1. Felder, C. C., and Glass, M. (1998) Cannabinoid receptors and their endogenous agonists, Annu. Rev. Pharmacol. Toxicol. 38, 179-200.
2. Lambert, D. M., and Fowler, C. J. (2005) The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications, J. Med. Chem. 48, 5059-5087.
3. Di Marzo, V., and De Petrocellis, L. (2006) Plant, synthetic, and endogenous cannabinoids in medicine, Annu. Rev. Med. 57, 553-574.
4. Pacher, P., Batkai, S., and Kunos, G. (2006) The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol. Rev. 58, 389-462.
5. Guzman, M. (2003) Cannabinoids: potential anticancer agents, Nat. Rev. Cancer 3, 745-755.
6. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., De- vane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mecholaum, R., and Pertwee, R. G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors, Pharmacol. Rev. 54,161-202.
7. Knight, P. J. K., Pfeifer, T. A., and Grigliatti, T. A. (2003) A functional assay for G-protein-coupled receptors using stably transformed insect tissue culture cell lines, Anal. Biochem. 320, 88-103.
8. Qureshi, A., and Faulkner, D.J. (1999) Haplosamates A and B: new steroidal sulfamate esters from two haplosclerid sponges, Tetrahedron 55, 8323-8330.
9. Fujita, M., Nakao, Y., Matsunaga, S., Seiki, M., Itoh, Y., Soest, R. W. M. V., Heubes, M., Faulkner, D. J., and Fusetani, N. (2001) Isolation and structure elucidation of two phosphorylated sterol sul- fates, MT1-MMP inhibitors from a marine sponge Cribrochalina sp.: revision of the structures of haplosamates A and B, Tetrahedron 57, 3885-3890.
10. Claasen, B., Axmann, M., Meinecke, R., and Meyer, B. (2005) Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectros- copy method shows a significantly higher affinity of integrin α(IIb)β(3) in native platelets than in liposomes, J. Am. Chem. Soc. 127,916-919.
11. Mayer, M., and Meyer, B. (1999)Characterization of ligand binding by saturation transfer difference NMR spectroscopy, Angew. Chem., Int. Ed. 38, 1784-1788.
12. Mayer, M., and Meyer, B. (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor, J. Am. Chem. Soc. 123, 6108-6117.
13. Meinecke, R., and Meyer, B. (2001) Determination ofthe binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin α(IIb)β(3), J. Med. Chem. 44, 3059-3065.
14. Neffe, A. T., Bilang, M., and Meyer, B. (2006) Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking, Org. Biomol. Chem. 4, 3259-3267.
15. Murata, T., Hemmi, H., Nakamura, S., Shimizu, K., Suzuki, Y., and Yamaguchi, J. (2005) Structure, epitope mapping, and docking simulation of a gib berellin mimic peptide as a peptidyl mimotope for a hydrophobic ligand, FEBSI. 272, 4938-4948.
16. Brecker, L., Straganz, G. D., Tyl, C. E., Steiner, W., and Nidetzky, B. (2006) Saturation-transfer-difference NMR to characterize substrate binding recognition and catalysis of two broadly specific glycoside hydrolases, J. Mol. Catal. B: Enzym. 42, 85-89.
17. Milton, M.J., Williamson, R. T., and Koehn, F. E. (2006) Mapping the bound conformation and protein interactions of microtubule destabilizing peptides by STD-NMR spectroscopy, Bioorg. Med. Chem. Lett. 16,4279-4282.
18. Megy, S., Bertho, G., Gharbi-Benarous, J., Baleux, F., Benarous, R., and Girault, J. P. (2006) STD and TRNOESY NMR studies for the epitope mapping of the phosphorylation motif of the oncogenic protein β-catenin recognized by a selective monoclonal antibody, FEBSLett. 580, 5411-5422.
19. Dyka, F. M., Wu, W. W., Pfeifer, T. A., Molday, L. L., Grigliatti, T. A., and Molday, R. S. (2008) Characterization and purification ofthe discoi- din domain-containing protein retinoschisin and its interaction with galactose, Biochemistry 47,9098-10106.